KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Return on Equity (2016 - 2025)

Edwards Lifesciences (EW) has 16 years of Return on Equity data on record, last reported at 0.0% in Q4 2025.

  • For Q4 2025, Return on Equity fell 28.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, down 28.0%, while the annual FY2025 figure was 0.0%, 33.0% down from the prior year.
  • Return on Equity reached 0.0% in Q4 2025 per EW's latest filing, down from 0.0% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.32% in Q3 2024 and bottomed at 0.0% in Q4 2025.
  • Average Return on Equity over 5 years is 0.18%, with a median of 0.23% recorded in 2022.
  • Peak YoY movement for Return on Equity: increased 27bps in 2024, then tumbled -32bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.26% in 2021, then dropped by -17bps to 0.22% in 2022, then crashed by -88bps to 0.03% in 2023, then surged by 957bps to 0.28% in 2024, then crashed by -100bps to 0.0% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.26% in Q2 2025.